CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
CBS9106 是一种新型可逆口服 CRM1 抑制剂,具有 CRM1 降解活性
期刊:Blood
影响因子:21
doi:10.1182/blood-2011-01-333138
Keiichi Sakakibara, Naoya Saito, Takuji Sato, Atsushi Suzuki, Yoko Hasegawa, Jonathan M Friedman, Donald W Kufe, Daniel D Vonhoff, Tadahiko Iwami, Takumi Kawabe